Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Daniel Joseph O’Connell, CEO of Acumen Pharmaceuticals, completed the sale of over 12,000 shares to satisfy tax liabilities tied to restricted stock units, under a pre-established trading plan. The company, focused on Alzheimer’s treatments, recently reported a net loss but continues progress in its clinical trials and collaboration with JCR Pharma…
Matt Zuga, Chief Financial Officer of Acumen Pharmaceuticals, completed stock sales totaling 4,160 shares valued at approximately $7,600 in late January 2026. These transactions were made to satisfy tax withholding obligations linked to vested restricted stock units, following a Rule 10b5-1 plan. Acumen remains focused on progressing Alzheimer’s tr…
On January 22, 2026, Lindblad Sven-Olof, a director and substantial shareholder of Lindblad Expeditions Holdings, Inc., sold 62,100 shares of the company's common stock, executing the transaction near the 52-week high price. The sale was conducted under a Rule 10b5-1 trading plan, generating proceeds exceeding $1 million. Amidst revenue growth and …
Derek M Meisner, Chief Legal Officer and Corporate Secretary of Acumen Pharmaceuticals, Inc., has conducted stock sales totaling $16,720 over three days in January 2026 under a pre-planned trading arrangement. These transactions come as the company continues to focus on its Alzheimer's treatment pipeline, including progressing clinical trials and c…
Aaron Tachibana, serving as CFO and COO of Personalis, Inc., engaged in significant insider transactions involving the purchase and sale of company shares on January 22, 2026. Concurrently, Personalis moves forward with Medicare reimbursement coverage for its advanced cancer monitoring tests and contemplates a sizable stock offering as it prepares …
Shannon L. Devers, Executive Vice President and Chief Human Resources Officer at Ionis Pharmaceuticals, completed a sale of nearly $323,500 worth of stock in late January 2026. The transaction occurred near the company’s 52-week high and precedes an anticipated earnings announcement. Meanwhile, Ionis continues progressing with recent regulatory app…
Following the United States’ formal withdrawal from the World Health Organization (WHO), California has become the first U.S. state to join the WHO’s Global Outbreak Alert and Response Network (GOARN). This move represents California’s commitment to global health collaboration and pandemic preparedness despite federal disengagement from the agency.
Chris Wren, Vice President of Operations at Planet 13 Holdings Inc, liquidated 30,000 company shares in late January 2026, amid the company's efforts to pivot its strategy following less-than-expected third-quarter earnings. Planet 13 reported $23.3 million in revenue and a negative EPS, prompting strategic exits including the California market to …
Amprius Technologies’ Chief Technology Officer, Stefan Constantin Ionel, recently sold over half a million shares totaling around $6.83 million while simultaneously exercising stock options. This activity unfolds during a period of significant stock appreciation and notable company initiatives including a new CEO transition and expanded production …
Michael F. MacLean, CFO of Avidity Biosciences Inc, executed a sale of 4,542 shares worth roughly $329,067 on January 21, 2026, in conformity with company equity incentive policies. The stock transaction occurred near its 52-week peak at $72.74 following a significant annual stock performance gain. In parallel, Avidity unveiled a Managed Access Pro…
Steven George Hughes, Chief Medical Officer at Avidity Biosciences, sold nearly 4,900 shares worth $354,642 to satisfy tax obligations related to recently vested Restricted Stock Units. This sale precedes multiple strategic developments at Avidity, including a new FDA-backed access program for its investigational muscular dystrophy therapy and an i…
W. Michael Flanagan, Chief Scientific Officer at Avidity Biosciences, recently sold 6,534 shares valued at approximately $473,388 to fulfill tax requirements related to restricted stock units. Meanwhile, Avidity is rolling out a Managed Access Program for its drug targeting Duchenne muscular dystrophy and has agreed to be acquired by Novartis in a …
On January 21, 2026, Avidity Biosciences’ President and CEO, Sarah Boyce, executed a sale of 14,387 shares in the company valued at approximately $1.04 million. The transaction, conducted near the stock's 52-week high, was performed to fulfill tax withholding on recently vested restricted stock units, as stipulated by the company's equity incentive…
The New York Federal Reserve carried out rate checks on the dollar/yen pair around midday on Friday, prompting a swift drop in the dollar against the yen. The checks - conducted by the NY Fed acting as fiscal agent for the U.S. Treasury - coincided with market caution about potential intervention as the yen neared 160 per dollar. The Bank of Japan …
On January 22, 2026, Comerica Executive Vice President James McGregor Carr completed a sale of 10,000 shares of company stock valued at roughly $980,600. This transaction occurred at prices close to the stock's annual peak and comes as Comerica pursues a merger with Fifth Third Bancorp, with recent earnings surpassing expectations.
William Radford Lovett II, a notable 10% shareholder of Dream Finders Homes, conducted a sizeable divestiture of Class A shares across two days in January 2026. These transactions unfolded while the company’s stock trades at a low price-to-earnings ratio, accompanied by a recent executive update on an expanded share repurchase plan and fresh market…
James Harry Weber, Executive Vice President of Comerica, executed significant stock sales and option exercises on January 22, 2026, coinciding with Comerica's robust stock performance and a pending merger. Despite Comerica's stock trading above its fair value and a high price-to-earnings ratio, the bank continues to demonstrate financial stability …
Rapid7's Chief Accounting Officer, Scott M. Murphy, has sold a portion of his holdings amid a significant year-over-year share price decline. The move comes ahead of an upcoming earnings report and follows mixed analyst opinions regarding the cybersecurity firm's growth prospects and valuation. Strategic initiatives including partnerships and produ…
Fitch Ratings has maintained Boston Scientific Corporation's credit ratings while upgrading their outlook to Positive from Stable following the removal of the Under Criteria Observation status. Fitch highlights Boston Scientific's robust business prospects, expecting significant revenue growth fueled by the recent $15 billion acquisition of Penumbr…
Fitch Ratings adjusted Turkey's sovereign outlook from stable to positive while maintaining its BB- long-term foreign-currency issuer default rating. This revision is underpinned by a notable strengthening of Turkey's external financial buffers, highlighted by a surge in gross foreign exchange reserves and a gradual reduction in vulnerabilities ass…
The United Steelworkers union has opened talks with Marathon Petroleum to establish a new multi-year contract governing workers at American refineries and chemical plants. With the existing agreement expiring shortly after midnight on February 1, the discussions hold significant implications for the labor force and the broader petrochemical sector.…
Fitch Ratings has maintained Serbia's Long-Term Foreign-Currency Issuer Default Rating at 'BB+', accompanied by a Positive Outlook. The rating agency attributes this stability to Serbia's sound policy framework and cautious fiscal discipline. Despite acknowledging strengths such as elevated GDP per capita and bolstered international reserves, Fitch…
Tyson Foods has announced a temporary continuation of limited beef processing at its Lexington, Nebraska slaughterhouse, despite plans to shut down the facility due to challenges stemming from tight cattle supplies. Approximately 292 employees will be retained for a transitional period ranging from three to 185 days to assist with closure-related a…
Fitch Ratings has upheld Kenya's Long-Term Foreign-Currency Issuer Default Rating at 'B-' with a stable outlook, recognizing the nation's robust medium-term growth prospects and diversified economy. Improvements in external liquidity and deliberate government actions to restructure external debt contribute to this assessment; however, ongoing fisca…
FCC Chairman Brendan Carr highlighted significant competition concerns surrounding Netflix's proposed acquisition of Warner Bros. Discovery's studios and streaming franchises, raising questions about market consolidation's impact in the streaming sector. However, he expressed less worry about a similar acquisition possibility involving Paramount an…
